Cas no 1379352-61-0 (5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine)
5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine
- CS-0309826
- P19405
- MFCD11043793
- 5-Bromo-2-(trifluoromethyl)-4-pyrimidinamine
- DTXSID60856969
- AS-79452
- DZWBVYLQAPRBOZ-UHFFFAOYSA-N
- 4-Amino-5-bromo-2-(trifluoromethyl)pyrimidine
- 4-Pyrimidinamine, 5-bromo-2-(trifluoromethyl)-
- 1379352-61-0
- DB-382060
- SCHEMBL23674888
- SB60118
- SY248842
-
- MDL: MFCD11043793
- Inchi: 1S/C5H3BrF3N3/c6-2-1-11-4(5(7,8)9)12-3(2)10/h1H,(H2,10,11,12)
- InChI Key: DZWBVYLQAPRBOZ-UHFFFAOYSA-N
- SMILES: BrC1C=NC(C(F)(F)F)=NC=1N
Computed Properties
- Exact Mass: 240.94624g/mol
- Monoisotopic Mass: 240.94624g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 163
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.5
- Topological Polar Surface Area: 51.8?2
5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A089004716-1g |
5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 95% | 1g |
$447.32 | 2022-04-02 | |
| Chemenu | CM164666-1g |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 95% | 1g |
$489 | 2021-08-05 | |
| Ambeed | A396412-10g |
5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 95+% | 10g |
$2739.0 | 2024-04-24 | |
| Chemenu | CM164666-1g |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 95% | 1g |
$812 | 2023-02-18 | |
| eNovation Chemicals LLC | D641844-100mg |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 97% | 100mg |
$195 | 2025-02-19 | |
| eNovation Chemicals LLC | D641844-250mg |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 97% | 250mg |
$295 | 2025-02-19 | |
| eNovation Chemicals LLC | D641844-1g |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 97% | 1g |
$745 | 2025-02-19 | |
| eNovation Chemicals LLC | D641844-500mg |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 97% | 500mg |
$495 | 2025-02-19 | |
| eNovation Chemicals LLC | D641844-5g |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 97% | 5g |
$2235 | 2025-02-19 | |
| eNovation Chemicals LLC | D641844-10g |
5-bromo-2-(trifluoromethyl)pyrimidin-4-amine |
1379352-61-0 | 97% | 10g |
$3730 | 2025-02-19 |
5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine Related Literature
-
Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
-
Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
-
3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
Additional information on 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine
5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine: A Comprehensive Overview
The compound 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine (CAS No. 1379352-61-0) is a highly specialized organic compound with significant applications in various fields of chemistry and materials science. This compound, characterized by its unique pyrimidine ring structure, has garnered attention due to its potential in drug discovery, electronic materials, and advanced chemical synthesis. The pyrimidine ring serves as a versatile scaffold for functionalization, enabling the incorporation of diverse substituents that enhance its reactivity and applicability.
Recent studies have highlighted the importance of 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine in the development of novel pharmaceutical agents. Researchers have explored its role as a precursor in the synthesis of bioactive molecules, particularly in the context of kinase inhibitors and other enzyme-targeting compounds. The presence of a bromo group at the 5-position and a trifluoromethyl group at the 2-position introduces unique electronic and steric properties, making it an ideal candidate for further functionalization. These substituents not only enhance the compound's stability but also facilitate selective reactivity in complex chemical transformations.
In the realm of materials science, 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine has been investigated for its potential in organic electronics. Its ability to form stable coordination complexes with metal ions has led to its consideration in the development of advanced materials for optoelectronic devices. Recent breakthroughs in this area have demonstrated that derivatives of this compound can exhibit desirable electronic properties, such as high charge carrier mobility and excellent thermal stability, which are critical for next-generation electronic applications.
The synthesis of 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine involves a multi-step process that combines traditional organic synthesis techniques with modern catalytic methods. Key steps include the formation of the pyrimidine ring through condensation reactions, followed by precise substitution at specific positions to introduce the bromo and trifluoromethyl groups. The optimization of reaction conditions has been a focal point for researchers aiming to improve yield and purity, ensuring that this compound can be produced on a larger scale for industrial applications.
One of the most promising areas of research involving 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine is its application in drug delivery systems. Scientists have explored its ability to act as a carrier for therapeutic agents, leveraging its structural flexibility to design targeted drug delivery vehicles. The compound's ability to form self-assembled structures under specific conditions has opened new avenues for nanotechnology-based drug delivery systems, which are increasingly sought after in modern medicine.
Furthermore, recent advancements in computational chemistry have enabled researchers to perform detailed molecular modeling studies on 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine. These studies have provided insights into its electronic structure, reactivity profiles, and potential interactions with biological systems. Such computational approaches are instrumental in guiding experimental efforts and accelerating the discovery of new applications for this compound.
In conclusion, 5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine (CAS No. 1379352610) stands as a testament to the ingenuity and precision of modern chemical synthesis. Its unique structural features and versatile reactivity make it a valuable tool across multiple disciplines. As research continues to uncover new applications and optimize existing ones, this compound is poised to play an increasingly important role in advancing both scientific knowledge and practical innovations.
1379352-61-0 (5-Bromo-2-(trifluoromethyl)pyrimidin-4-amine) Related Products
- 672-42-4(2-(Trifluoromethyl)pyrimidin-4-amine)
- 672-46-8(2-(Trifluoromethyl)pyrimidine-4,6-diamine)
- 2137813-31-9(5-Bromo-6-methyl-2-(trifluoromethyl)pyrimidin-4-amine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)